Full Press Release Details
Contact Us
To learn more about Vivani, and to learn more about our strategic focus on NPM-139 (semaglutide implant), please fill out this form.
VANI Positive Sentiment
Vivani Medical to Present at TIDES Conference 2024
Key Takeaway: Vivani Medical is set to present at the TIDES Conference 2024, showcasing their strategic focus on NPM-139, a semaglutide implant. This participation underscores their commitment to innovation in biopharma. The conference will provide a platform for Vivani to highlight their advancements and engage with industry peers.
Price reaction · baseline $1.7 (2024-05-08 close) · hit pre-market · 2 other VANI headline(s) in the window, move may be shared
day 0 close · peak
+1.2%
Market Sentiment Analysis
POSITIVE FACTORS
- Vivani Medical is actively engaging in industry conferences.
- The presentation at TIDES Conference 2024 highlights their innovative approach.
- Focus on NPM-139 (semaglutide implant) indicates a commitment to advancing treatments.
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial adviceCash runway
~10 mo
Medium dilution risk
Lead asset
Semaglutide
Phase 1 · Obesity & Overweight
Frequently Asked Questions
What will Vivani Medical present at TIDES Conference 2024?
Vivani Medical will present their strategic focus on NPM-139, a semaglutide implant.
Why is Vivani Medical participating in TIDES Conference 2024?
Their participation highlights their commitment to innovation in the biopharma sector.